#USA #Madrid #LifeSphere #ArisGlobal #NavaX

ArisGlobal's Groundbreaking Announcements at Breakthrough 2026

ArisGlobal, a leading technology firm in the life sciences sector, recently made headlines with the announcement of five new significant products during its annual event, Breakthrough 2026, held in Madrid, Spain. The company introduced the XDI Data Intelligence platform, three new AI agents, and NavaX Translation, all aimed at enhancing the operational efficiency of pharmaceutical research and development teams.

XDI: A Cutting-Edge Data Intelligence Cortex

At the forefront of these announcements is XDI, which stands for eXplainable Data Intelligence. This innovative platform serves as a data intelligence cortex capable of accessing and integrating information from diverse functions and systems. The goal of XDI is to support coherent and intelligible decision-making across various departments in the pharmaceutical research and development realm. Unlike existing tools that expedite workflow, XDI is designed to provide a unified context, ensuring that decisions made in Safety, Regulatory, Clinical, Quality, and Manufacturing are based on shared meanings and aligned evidence. In doing so, ArisGlobal aims to foster a more confident adoption of AI technologies, thereby minimizing risks associated with interpretative variations across teams and use cases.

Expanding the NavaX Agents Suite

Moreover, the NavaX Agents Suite has seen an expansion with the introduction of three new agents:
1. Intelligence Agents: These agents revolutionize submission quality by interpreting regulatory guidelines and converting them into precise rule checklists, thereby enhancing the compliance evaluations of dossiers processed through LifeSphere Submissions.
2. Distribution Agents: They facilitate continuous compliance validation by automatically adapting to evolving regulatory standards, ensuring that discrepancies trigger appropriate change workflows.
3. Signals Agents: As intelligent assistants, these agents determine user intent and dynamically plan and execute necessary workflows by harnessing advanced analytical techniques.

Collectively, these agents empower life sciences teams to make smarter, more informed decisions by ensuring compliance and synchronized operations across all departments.

Transforming Data Intake with NavaX Translation

In an increasingly globalized industry, ArisGlobal announced the introduction of the NavaX Translation feature, which integrates certified translation capabilities into case data intake workflows. Through a partnership with TransPerfect Life Sciences, ArisGlobal can now support intelligent language detection that routes non-English safety forms for instant translations by expert linguists. This automated process significantly reduces the time spent on translation management from approximately five hours per case to under one minute, thus enhancing the speed and accuracy of global pharmacovigilance operations.

Vision for the Future

Aman Wasan, CEO of ArisGlobal, emphasized the importance of not just adopting AI technologies, but operationalizing them effectively to achieve real-world impact. He remarked, "The challenge for life sciences isn't just adopting AI - it's operationalizing it at scale with consistency, governance, and real business impact." Ann-Marie Orange, the CIO and Global Head of R&D at ArisGlobal, also noted that these innovations signify a paradigm shift from merely automating tasks to orchestrating intelligence across entire operational ecosystems, leading to smarter decisions and faster insights.

The Breakthrough 2026 event was not merely a showcase of new products; it served as a significant forum for industry leaders to discuss how proven AI practices can reshape everyday operations in the life sciences sector.

For further insights and updates, visit ArisGlobal's official website or connect with them on LinkedIn.